Skip to main content
Advanced Technical IVT

HRD

Pronunciation: H-R-D

Also written as: HRD — Homologous Recombination Deficiency

Homologous Recombination Deficiency, a genomic instability pattern predictive of PARP inhibitor response.

Full Definition

HRD (Homologous Recombination Deficiency) represents impaired ability to repair double-strand DNA breaks through homologous recombination, often resulting from BRCA1/2 mutations or other pathway alterations. HRD tumors exhibit characteristic genomic scarring patterns including loss of heterozygosity, telomeric allelic imbalance, and large-scale state transitions. HRD scoring algorithms combine these signatures to predict sensitivity to PARP inhibitors and platinum chemotherapy. Editors must understand that HRD can result from various mechanisms beyond BRCA mutations and that HRD scores may vary between different commercial assays and scoring methodologies.

Usage

Usage note: Capitalize as HRD. Include specific HRD score when available and specify the scoring algorithm used.

In Context

  • "The HRD score of 42 indicated significant genomic instability and potential PARP inhibitor sensitivity." — precision oncology report
  • "HRD-positive ovarian cancers demonstrated superior response rates to olaparib maintenance therapy." — clinical trial results

Also known as

homologous recombination deficiency

Contrasted with

HRP homologous recombination proficiency

Don't confuse with

BRCA mutation dMMR

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON